CoChat

Methods and processes of the CONSORT group: example of an extension for trials assessing nonpharmacologic treatments.

Boutron, Isabelle, Moher, David, Altman, Douglas G., Schulz, Kenneth F., Ravaud, Philippe, for the CONSORT Group* · 2008 · Annals of Internal Medicine

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The conduct of randomized, controlled trials of nonpharmacologic treatments presents specific challenges that are not adequately addressed in trial reports. OBJECTIVE: To develop an extension of the CONSORT (Consolidated Standards of Reporting Trials) Statement for trials of nonpharmacologic treatments. DESIGN: A consensus meeting was organized to develop an extension of the CONSORT Statement that addresses randomized trials of nonpharmacologic treatments. To prepare for the meeting, a survey was conducted to identify the specific issues for discussion. SETTING: Consensus meeting in Paris, France. PARTICIPANTS: A total of 33 experts attended the meeting. The experts were methodologists (n = 17); surgeons (n = 6); editors (n = 5); and clinicians involved in rehabilitation (n = 1), psychotherapy (n = 2), education (n = 1), and implantable devices (n = 1). MEASUREMENTS: Experts indicated which of the 22 items on the CONSORT checklist should be modified or which additional items should be added specifically for nonpharmacologic treatments. During a 3-day consensus meeting, all items were discussed and additional methodological issues related to nonpharmacologic research were identified. RESULTS: The consensus was that 11 items on the CONSORT checklist needed some modifications for nonpharmacologic trials: item 1 (title and abstract), item 3 (participants), item 4 (interventions), item 7 (sample size), item 8 (randomization), item 11 (blinding), item 12 (statistical methods), item 13 (participant flow), item 15 (baseline data), item 20 (discussion: interpretation), and item 21 (generalizability). In addition, the meeting participants added 1 item related to implementation of the intervention. LIMITATION: Evidence was not always available to support the inclusion of each checklist item. CONCLUSION: The methods and processes used to develop this extension could be used for other reporting guidelines. The use of this extension to the CONSORT Statement should improve the quality of reporting randomized, controlled trials assessing nonpharmacologic treatments.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-148-4-200802190-00008-w1

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

See all 523

Metadata

Authors
Boutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group*
Affiliations
Family Health International 360 (US)
Venue
Annals of Internal Medicine
Published
2008-02-19
Volume
148
Issue
4
Pages
W-60-W-66
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2097554458
Cited by
523
References
34
Citations by year
2026: 4 · 2025: 21 · 2024: 22 · 2023: 12 · 2022: 16 · 2021: 15 · 2020: 35 · 2019: 23 · 2018: 34 · 2017: 34 · 2016: 50 · 2015: 38 · 2014: 47 · 2013: 43 · 2012: 32
FWCI
36.30
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Sociology and Political Science › Delphi Technique in Research
Keywords
CONSORT statement, non-pharmacological treatment, reporting guidelines, randomized controlled trials, trial reporting quality, intervention implementation, blinding, randomization, sample size, participant flow
MeSH terms
Publishing, Quality Control, Research Design, Therapeutics, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methods and processes of the CONSORT group: example of an extension for trials assessing nonpharmacologic treatments. https://app.cochat.ai/papers/10.7326/0003-4819-148-4-200802190-00008-w1
The paper
Boutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group*. (2008). Methods and processes of the CONSORT group: example of an extension for trials assessing nonpharmacologic treatments. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-148-4-200802190-00008-w1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.